Dacomatinib is now available in India for EGFR Positive Lung Cancer. This drug is better than first generation gefitinib and second generation afatinib in many senses.
(22-June-2020)
Dacomatinib is now available in India for EGFR Positive Lung Cancer. This drug is better than first generation gefitinib and second generation afatinib in many senses.
Other News
-
(18/11/2020)
-
(18/11/2020)
-
(18/11/2020)
-
(7/11/2020)
-
(4/11/2020)
-
(2/9/2020)
-
(29/8/2020)
-
(28/8/2020)
-
(10/7/2020)
-
(17/6/2020)
-
(25/5/2020)
-
(20/5/2020)
-
(9/5/2020)
-
(25/4/2020)
-
(21/4/2020)
-
(9/4/2020)
-
(14/2/2020)
-
(11/2/2020)
-
(4/1/2020)
-
(30/12/2019)
-
(9/10/2019)
-
(5/9/2019)
-
(17/8/2019)
-
(6/8/2019)
-
(1/5/2019)
-
(27/3/2019)
-
(19/3/2019)
-
(19/3/2019)
-
(20/9/2018)
-
(9/8/2018)
-
(9/8/2018)
-
(26/7/2018)
-
(29/5/2018)
-
(1/4/2018)
-
(31/3/2018)
-
(7/3/2018)
-
(4/3/2018)
-
(23/2/2018)
-
(20/2/2018)
-
(13/1/2018)
-
(8/1/2018)
-
(28/10/2017)
-
(1/9/2017)
-
(25/8/2017)
-
(20/7/2017)
-
(14/7/2017)
-
(21/6/2017)
-
(13/6/2017)
-
(1/6/2017)
-
(1/6/2017)
-
(8/5/2017)
-
(5/5/2017)
-
(29/4/2017)
-
(5/4/2017)
-
(10/3/2017)
-
(8/2/2017)
-
(12/9/2016)
-
(3/8/2016)
-
(2/8/2016)
-
(24/5/2016)
-
(7/5/2016)
-
(31/3/2016)
-
(31/3/2016)
-
(28/3/2016)
-
(28/3/2016)
-
(28/3/2016)
-
(17/2/2016)
-
(7/1/2016)
-
(29/10/2015)
-
(18/8/2015)
-
(11/8/2015)
-
(8/8/2015)
-
(24/7/2015)
-
(29/1/2015)
-
(29/1/2015)
-
(11/12/2014)
-
(18/8/2014)
-
(18/8/2014)
-
(18/8/2014)
-
(2/9/2013)
-
(14/8/2013)
-
(13/7/2013)
-
(2/5/2013)
-
(4/4/2013)
-
(13/3/2013)
-
(26/12/2012)
-
(26/12/2012)
-
(2/11/2012)
-
(25/5/2012)
-
(3/2/2012)
-
(9/12/2011)